Spacers Increase the Accessibility of Peptide Ligands Linked to the Carboxyl Terminus of Adenovirus Minor Capsid Protein IX
暂无分享,去创建一个
Jort Vellinga | Diana J M van den Wollenberg | Martijn J W E Rabelink | Rob C Hoeben | Steve J Cramer | Hans Van der Meulen | Keith N Leppard | Frits J Fallaux | M. Rabelink | K. Leppard | R. Hoeben | S. Cramer | D. V. D. van den Wollenberg | J. Vellinga | F. J. Fallaux | H. van der Meulen | F. Fallaux
[1] Erkki Ruoslahti,et al. αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.
[2] D. Curiel,et al. Modulation of Adenovirus Vector Tropism via Incorporation of Polypeptide Ligands into the Fiber Protein , 2002, Journal of Virology.
[3] R. M. Burnett,et al. Molecular composition of the adenovirus type 2 virion , 1985, Journal of virology.
[4] D. Brough,et al. The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F , 1998, Journal of Virology.
[5] J. T. Douglas. Targeted adenoviral vectors , 2002 .
[6] J. Bergelson,et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Bewley,et al. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. , 1999, Science.
[8] A. Houweling,et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. , 1996, Human gene therapy.
[9] Senén Vilaró,et al. RGD Peptides and Monoclonal Antibodies, Antagonists of αv-Integrin, Enter the Cells by Independent Endocytic Pathways , 2001, Laboratory Investigation.
[10] R. M. Burnett,et al. Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography. , 1989, The EMBO journal.
[11] M. Magnusson,et al. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability , 2002, The journal of gene medicine.
[12] H. Granzow,et al. The Subgenus-Specific C-Terminal Region of Protein IX Is Located on the Surface of the Adenovirus Capsid , 1999, Journal of Virology.
[13] E Ruoslahti,et al. Solution structures and integrin binding activities of an RGD peptide with two isomers. , 2001, Biochemistry.
[14] D. Curiel,et al. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism , 1996, Journal of virology.
[15] D. Curiel,et al. Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 Fibritin , 2001, Journal of Virology.
[16] U. Pettersson,et al. Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2. , 1973, Virology.
[17] G. Nemerow. Cell receptors involved in adenovirus entry. , 2000, Virology.
[18] A. van der Eb,et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. , 1998, Human gene therapy.
[19] Roger M. Burnett,et al. Image reconstruction reveals the complex molecular organization of adenovirus , 1991, Cell.
[20] D. Curiel,et al. Engineering of Adenovirus Vectors Containing Heterologous Peptide Sequences in the C Terminus of Capsid Protein IX , 2002, Journal of Virology.
[21] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[22] K. Kinzler,et al. A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Brough,et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins , 1997, Journal of virology.
[24] H. Hamada,et al. Reduction of Natural Adenovirus Tropism to the Liver by both Ablation of Fiber-Coxsackievirus and Adenovirus Receptor Interaction and Use of Replaceable Short Fiber , 2003, Journal of Virology.
[25] G. Molema,et al. Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[26] M. Dabauvalle,et al. Cellular uptake and nuclear delivery of recombinant adenovirus penton base. , 1999, Virology.
[27] J. Bos,et al. Role of adenovirus types 5 and 12 early region 1b tumor antigens in oncogenic transformation. , 1983, Virology.
[28] S. J. Flint,et al. Interactions among the three adenovirus core proteins , 1985, Journal of virology.
[29] P. Nygren,et al. Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. , 2002, Human gene therapy.
[30] P. Stewart,et al. Difference imaging of adenovirus: bridging the resolution gap between X‐ray crystallography and electron microscopy. , 1993, The EMBO journal.
[31] F. Graham,et al. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. , 1995, Human gene therapy.
[32] W. Russell,et al. Update on adenovirus and its vectors. , 2000, The Journal of general virology.
[33] G. Nemerow,et al. Adenovirus Vector Pseudotyping in Fiber-Expressing Cell Lines: Improved Transduction of Epstein-Barr Virus-Transformed B Cells , 2000, Journal of Virology.
[34] H. Mizuguchi,et al. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. , 2002, Gene.
[35] T. Shenk,et al. Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX , 1981, Journal of virology.
[36] R. Crystal,et al. Fiber Swap between Adenovirus Subgroups B and C Alters Intracellular Trafficking of Adenovirus Gene Transfer Vectors , 1999, Journal of Virology.
[37] B. Trapnell,et al. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.
[38] H. Pereira,et al. Antigens and structure of the adenovirus , 2003, Journal of molecular biology.
[39] K. Leppard,et al. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5 , 1995, Journal of virology.
[40] J. Gall,et al. Subgroup B and F Fiber Chimeras Eliminate Normal Adenovirus Type 5 Vector Transduction In Vitro and In Vivo , 2003, Journal of Virology.
[41] J. Bergelson,et al. Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.
[42] P. Boulanger,et al. Characterization of adenovirus protein IX. , 1979, The Journal of general virology.
[43] N R Kallenbach,et al. Structural analysis of the N‐ and C‐termini in a peptide with consensus sequence , 1995, Protein science : a publication of the Protein Society.
[44] C. Kedinger,et al. Functional Analysis of Adenovirus Protein IX Identifies Domains Involved in Capsid Stability, Transcriptional Activity, and Nuclear Reorganization , 2001, Journal of Virology.
[45] A. Kidd,et al. Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor , 2000, Journal of Virology.
[46] S. Khoo,et al. Adenoviruses from Human Immunodeficiency Virus-Infected Individuals, Including Two Strains That Represent New Candidate Serotypes Ad50 and Ad51 of Species B1 and D, Respectively , 1999, Journal of Clinical Microbiology.
[47] U. Pettersson,et al. Structural proteins of adenoviruses , 1971 .
[48] T. Wickham,et al. Targeting adenovirus , 2000, Gene Therapy.
[49] Manfred Schwab,et al. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. , 2002, Cancer research.
[50] R. Auerbach,et al. A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[51] F. Graham,et al. Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. , 1987, The EMBO journal.
[52] P. Boulanger,et al. Human adenovirus type 2 protein IIIa. II. Maturation and encapsidation. , 1980, Virology.
[53] R. Miceli,et al. Two-stage selection of sequences from a random phage display library delineates both core residues and permitted structural range within an epitope. , 1994, Journal of immunological methods.